CADTH will begin posting patient input submissions, received on or after February 1, 2014, for drugs reviewed through the Common Drug Review.
Earlier this year CADTH invited stakeholder comments and feedback regarding its posting of Patient Input Submissions (CDR Update — Issue 89). After considering the feedback received, CADTH has finalized its procedure for posting the patient input submissions on its website. Details on the procedures, instructions for submitting and the template for submission is accessible in CDR Update – Issue 99.
Clarification on Category 2 Submission Requirements and Timing
CDR Update – Issue 98 outlined revised Category 2 requirements for all submissions, and revised target date for submitting pre-Notice of Compliance (NOC) Category 2 requirements. Note that these revisions do not apply to CDR submissions that are currently under review or queued, and those that are received by CADTH before February 5, 2014